WallStreetZenWallStreetZen

NASDAQ: OPRX
Optimizerx Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for OPRX

Based on 4 analysts offering 12 month price targets for Optimizerx Corp.
Min Forecast
$13.00+47.73%
Avg Forecast
$15.00+70.45%
Max Forecast
$17.00+93.18%

Should I buy or sell OPRX stock?

Based on 4 analysts offering ratings for Optimizerx Corp.
Buy
Strong Buy
1 analysts 25%
Buy
2 analysts 50%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OPRX stock forecasts and price targets.

OPRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-16
lockedlocked$00.00+00.00%2024-04-01
lockedlocked$00.00+00.00%2024-04-01
lockedlocked$00.00+00.00%2024-01-03

1 of 1

Forecast return on equity

Is OPRX forecast to generate an efficient return?
Company
N/A
Industry
8.12%
Market
31.36%

Forecast return on assets

Is OPRX forecast to generate an efficient return on assets?
Company
N/A
Industry
6.33%

OPRX revenue forecast

What is OPRX's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$100.9M+41.13%
Avg 2 year Forecast
$115.4M+61.39%
OPRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OPRX revenue growth forecast

How is OPRX forecast to perform vs Health Information Services companies and vs the US market?
Company
41.13%
Industry
13.32%
Market
12.87%
OPRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OPRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OPRX vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
OPRX$8.80$15.00+70.45%Buy
AMWL$0.54$1.00+85.53%Hold
AONC$3.89N/AN/A
AUGX$2.79N/AN/A
LIFW$0.94N/AN/A
View Top Health Information Service Stocks

Optimizerx Stock Forecast FAQ

Is Optimizerx Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: OPRX) stock is to Buy OPRX stock.

Out of 4 analysts, 1 (25%) are recommending OPRX as a Strong Buy, 2 (50%) are recommending OPRX as a Buy, 1 (25%) are recommending OPRX as a Hold, 0 (0%) are recommending OPRX as a Sell, and 0 (0%) are recommending OPRX as a Strong Sell.

If you're new to stock investing, here's how to buy Optimizerx stock.

What is OPRX's revenue growth forecast for 2024-2025?

(NASDAQ: OPRX) Optimizerx's forecast annual revenue growth rate of 41.13% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 13.32%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.87%.

Optimizerx's revenue in 2024 is $71,521,506.On average, 1 Wall Street analysts forecast OPRX's revenue for 2024 to be $1,835,484,279, with the lowest OPRX revenue forecast at $1,835,484,279, and the highest OPRX revenue forecast at $1,835,484,279.

In 2025, OPRX is forecast to generate $2,098,951,009 in revenue, with the lowest revenue forecast at $2,064,783,435 and the highest revenue forecast at $2,133,136,767.

What is OPRX's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: OPRX) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of 6.33%.

What is OPRX's Price Target?

According to 4 Wall Street analysts that have issued a 1 year OPRX price target, the average OPRX price target is $15.00, with the highest OPRX stock price forecast at $17.00 and the lowest OPRX stock price forecast at $13.00.

On average, Wall Street analysts predict that Optimizerx's share price could reach $15.00 by Apr 16, 2025. The average Optimizerx stock price prediction forecasts a potential upside of 70.45% from the current OPRX share price of $8.80.

What is OPRX's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: OPRX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.